消息
×
loading..
中文版 | English

在结果中检索

KMS

浏览/检索结果: 共29条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
IHCH9033, a novel class I HDAC inhibitor, synergizes with FLT3 inhibitor and rescues quizartinib resistance in FLT3-ITD AML via enhancing DNA damage response 期刊论文
EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2025, 卷号: 14, 期号: 1
作者:  Yao, Mingyue;  Yan, Wenzhong;  Wang, Yafang;  Zhao, Yu;  Xu, Xiaowei
Adobe PDF(14589Kb)  |  收藏  |  浏览/下载：99/4  |  提交时间：2025/03/03
Emerging horizons in cancer therapy: Squamous transition drives drug resistance 期刊论文
CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 卷号: 14, 期号: 6
作者:  Zhang, Ningxia;  Tong, Xinyuan;  Ji, Hongbin
Adobe PDF(432Kb)  |  收藏  |  浏览/下载：259/1  |  提交时间：2024/07/08
Targeting Tumor Heterogeneity by Breaking a Stem Cell and Epithelial Niche Interaction Loop 期刊论文
ADVANCED SCIENCE, 2024, 卷号: 11, 期号: 26
作者:  Ma, Rongze;  Feng, Deyi;  Chen, Jing;  Zhou, Jiecan;  Xia, Kun
Adobe PDF(25931Kb)  |  收藏  |  浏览/下载：253/9  |  提交时间：2024/05/20
Targeting ST8SIA6-AS1 counteracts KRASG12C inhibitor resistance through abolishing the reciprocal activation of PLK1/c-Myc signaling 期刊论文
EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2023
作者:  Yafang Wang;  Mingyue Yao;  Cheng Li (李成);  Kexin Yang;  Xiaolong Qin
Adobe PDF(16153Kb)  |  收藏  |  浏览/下载：394/5  |  提交时间：2024/09/02
Applications of macrocyclic molecules in cancer therapy: Target cancer development or overcome drug resistance 期刊论文
MEDCOMM-ONCOLOGY, 2023, 卷号: 2, 期号: e50
作者:  Xiaoling Song;  Yifan Wu;  Xiaojuan Qu;  Biao Jiang
Adobe PDF(2797Kb)  |  收藏  |  浏览/下载：583/7  |  提交时间：2023/09/05
Construction and characterization of a new hepatitis C virus genotype 6a subgenomic replicon that is prone to render the sofosbuvir resistance 期刊论文
JOURNAL OF MEDICAL VIROLOGY, 2023, 卷号: 95, 期号: 9
作者:  Liu, Chaolun;  Guo, Mingzhe;  Han, Lin;  Lu, Jie;  Xiang, Xiaogang
Adobe PDF(5953Kb)  |  收藏  |  浏览/下载：292/0  |  提交时间：2023/10/31
EZH2 W113C is a gain-of-function mutation in B-cell lymphoma enabling both PRC2 methyltransferase activation and tazemetostat resistance 期刊论文
JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 卷号: 299, 期号: 4
作者:  Chu, Liping
Adobe PDF(3768Kb)  |  收藏  |  浏览/下载：618/1  |  提交时间：2023/04/07
Syntaxin-6 promotes the progression of hepatocellular carcinoma and alters its sensitivity to chemotherapies by activating the USF2/LC3B axis 期刊论文
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2023, 卷号: 19, 期号: 12
作者:  
Adobe PDF(10159Kb)  |  收藏  |  浏览/下载：542/165  |  提交时间：2023/09/08
Discovery and characterization of novel potent BCR-ABL degraders by conjugating allosteric inhibitor 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 244
作者:  Liu, Haixia;  Mi, Qianglong;  Ding, Xinyu;  Lin, Chencen;  Liu, Linyi
Adobe PDF(6603Kb)  |  收藏  |  浏览/下载：781/12  |  提交时间：2022/11/08
P300/CBP inhibition sensitizes mantle cell lymphoma to PI3K delta inhibitor idelalisib 期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
作者:  Zhou, Xiao-ru;  Li, Xiao;  Liao, Li-ping;  Han, Jie;  Huang, Jing
Adobe PDF(5109Kb)  |  收藏  |  浏览/下载：398/1  |  提交时间：2021/05/14
  • 首页
  • 上一页
  • 1
  • 2
  • 3
  • 下一页
  • 末页